IQVIA™ Real-World Insights Bibliography

Economic evaluation of surgical treatment vs. Imiquimod 5% cream in patients with Superficial Basal Cell Carcinoma
Author(s): Vanaclocha F, Badia X, Guillén V, Sánchez J, Sáinz de los Terreros M, Llorens MA.
Affiliations(s): 
Publication(s):  Br J Dermatol. 2007 Apr;156(4):769-71.
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Health economics, Oncology,
2006
  L:
A:
English
  Add to report
 
 
Costs of chemotherapy for indolent follicular nonHodgkin?s lymphoma in the UK: an observational study.
Author(s): Hutchinson J1, Lloyd A1, Gray A2, Gale R3, Hancock B4.
Affiliations(s): 1 Fourth Hurdle Consulting, London, UK 2 Health Economics Research Centre, Oxford University, Oxford UK 3 Schering Health Care, West Sussex, UK 4 School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
Publication(s):  Acta Haematol. 2006;115(1-2):28-34.
Document Type(s): Manuscript in preparation,
Countries: UK,
C:
Y:
Oncology,
2006
  L:
A:
English
Cost of illness,
  Add to report
 
 
An update: Health economics of managing multiple myeloma
Author(s): K Moeremans, L Annemans.
Affiliations(s): 
Publication(s):  European Journal of Cancer, 2006; 42(11):1684-96
Document Type(s): Manuscript in preparation,
Countries: Belgium,
C:
Y:
Oncology,
2006
  L:
A:
English
  Add to report
 
 
High energy transurethral microwave thermotherapy for benign prostatic hyperplasia. Assessment report.
Author(s): Medicare Services Advisory Committee (MSAC).
Affiliations(s): 
Publication(s):  Department of Health and Ageing, Commonwealth of Australia. Canberra.
Document Type(s): Manuscript in preparation,
Countries: Australia,
C:
Y:
Oncology,
2006
  L:
A:
English
  Add to report
 
 
Validity of tests for initial diagnosis and its concordance with final diagnosis in patients with suspected benign prostatic hyperplasia
Author(s): Carballido J, Badia X, Gimeno A, Regadera L, Dal-Ré L, Guilera M
Affiliations(s): 
Publication(s):  Actas Urol Esp 2006;30(7):667-4
Document Type(s): Article,
Countries: Spain,
C:
Y:
Oncology,
2006
  L:
A:
Spanish
Quality of life,
  Add to report
 
 
Cost effectiveness of cetuximab in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in Spain
Author(s): Brosa M, Robinson P Brown B
Affiliations(s): Max Brosa, , Director1, Paul Robinson, BSc, MSc, Senior Economist2, Ben Brown, MSc, Economist21Oblikue Consulting, Barcelona, SC, Spain; 2 IMS Health Economics & Outcomes Research, London, United Kingdom
Publication(s): 
ISPOR Ninth Annual European Congress Copenhagen, Denmark October, 2006
Document Type(s): Poster,
Countries: Spain,
C:
Y:
Oncology,
2006
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Cost-effectiveness of cetuximab (Erbitux®) in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in France
Author(s): Brown B, Roninson P, Launois R, Griebsch I
Affiliations(s): 
Publication(s): 
Document Type(s): Poster,
Countries: France,
C:
Y:
Oncology,
2006
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Cost-effectiveness analysis of adjuvant therapy with trastuzumab (Herceptin) for the treatment of breast cancer in inicial stages.
Author(s): Polanco Sánchez C, Rodríguez Sánchez C, Sánchez-Rovira P, Barnadas Molins A, Sabater Torres FJ, Álvarez Sanz C.
Affiliations(s): 
Publication(s):  VII Scientific Meeting of the Asociación Española de Evaluación de Tecnologías Sanitarias (Spanish Association of Health Technology Evaluation), Sevilla (Spain) 16-17 November
Document Type(s): Poster,
Countries: 
C:
Y:
Oncology,
2006
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Cost-effectiveness of pemetrexed plus cisplatin versus cisplatin alone in the treatment of malignant pleural mesothelioma
Author(s): Davey P, Cordony A, Rajan N, Arora B, Pavlakis N.
Affiliations(s): 
Publication(s):  ISPOR 2nd Asia-Pacific conference
ISPOR 2nd Asia-Pacific conference, Worldfield Convention Hotel, Shanghai, China
Document Type(s): Poster,
Countries: 
C:
Y:
Oncology, Respiratory disease,
2006
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Cost-effectiveness of pemetrexedplus cisplatin versus cisplatin alone in the treatment of malignant pleuralmesothelioma.
Author(s): Davey P, Cordony a, Rajan N, Arora B, Pavlakis
Affiliations(s): 
Publication(s):  ISPOR 2nd Asia-Pacific Congress,Shanghai, China
Document Type(s): Poster,
Countries: 
C:
Y:
Oncology,
2006
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
First Page Previous Page  58 of 58